AnaptysBio
ANAB
ANAB
164 hedge funds and large institutions have $981M invested in AnaptysBio in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 59 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
12.01% less ownership
Funds ownership: 125.17% → 113.16% (-12%)
27% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 59
38% less call options, than puts
Call options by funds: $9.37M | Put options by funds: $15.1M
Holders
164
Holding in Top 10
5
Calls
$9.37M
Puts
$15.1M
Top Buyers
| 1 | +$40.3M | |
| 2 | +$25.2M | |
| 3 | +$9.34M | |
| 4 |
D.E. Shaw & Co
New York
|
+$7.26M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$6.73M |
Top Sellers
| 1 | -$78.1M | |
| 2 | -$75.3M | |
| 3 | -$36.7M | |
| 4 |
Citigroup
New York
|
-$29.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$29.1M |
